JP2017014206A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017014206A5 JP2017014206A5 JP2016128584A JP2016128584A JP2017014206A5 JP 2017014206 A5 JP2017014206 A5 JP 2017014206A5 JP 2016128584 A JP2016128584 A JP 2016128584A JP 2016128584 A JP2016128584 A JP 2016128584A JP 2017014206 A5 JP2017014206 A5 JP 2017014206A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- day
- patient
- months
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562186638P | 2015-06-30 | 2015-06-30 | |
| US62/186,638 | 2015-06-30 | ||
| US201562267510P | 2015-12-15 | 2015-12-15 | |
| US62/267,510 | 2015-12-15 | ||
| US201662321558P | 2016-04-12 | 2016-04-12 | |
| US62/321,558 | 2016-04-12 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018145654A Division JP2018172440A (ja) | 2015-06-30 | 2018-08-02 | 腹水の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017014206A JP2017014206A (ja) | 2017-01-19 |
| JP2017014206A5 true JP2017014206A5 (enExample) | 2017-08-31 |
Family
ID=57609113
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016128584A Pending JP2017014206A (ja) | 2015-06-30 | 2016-06-29 | 腹水の治療 |
| JP2018145654A Pending JP2018172440A (ja) | 2015-06-30 | 2018-08-02 | 腹水の治療 |
| JP2020115254A Pending JP2020172520A (ja) | 2015-06-30 | 2020-07-03 | 腹水の治療 |
| JP2022107055A Pending JP2022136104A (ja) | 2015-06-30 | 2022-07-01 | 腹水の治療 |
| JP2023133333A Pending JP2023160839A (ja) | 2015-06-30 | 2023-08-18 | 腹水の治療 |
| JP2025107051A Pending JP2025143324A (ja) | 2015-06-30 | 2025-06-25 | 腹水の治療 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018145654A Pending JP2018172440A (ja) | 2015-06-30 | 2018-08-02 | 腹水の治療 |
| JP2020115254A Pending JP2020172520A (ja) | 2015-06-30 | 2020-07-03 | 腹水の治療 |
| JP2022107055A Pending JP2022136104A (ja) | 2015-06-30 | 2022-07-01 | 腹水の治療 |
| JP2023133333A Pending JP2023160839A (ja) | 2015-06-30 | 2023-08-18 | 腹水の治療 |
| JP2025107051A Pending JP2025143324A (ja) | 2015-06-30 | 2025-06-25 | 腹水の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (6) | US9655945B2 (enExample) |
| EP (2) | EP4338795A3 (enExample) |
| JP (6) | JP2017014206A (enExample) |
| CN (2) | CN106999539A (enExample) |
| ES (1) | ES2971959T3 (enExample) |
| HK (1) | HK1258611A1 (enExample) |
| WO (1) | WO2017004317A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ591810A (en) | 2008-09-17 | 2012-12-21 | Chiasma Inc | Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid |
| HRP20220225T1 (hr) | 2014-10-24 | 2022-04-29 | Mallinckrodt Pharmaceuticals Ireland Limited | Terlipresin za liječenje hepatorenalnog sindroma tip 1 |
| PL3253401T3 (pl) | 2015-02-03 | 2025-08-04 | Amryt Endo, Inc. | Leczenie akromegalii oktreotydem doustnym |
| JP2017014206A (ja) * | 2015-06-30 | 2017-01-19 | ナノアンティバイオティクス，インコーポレイテッド | 腹水の治療 |
| IL265761B2 (en) | 2016-10-21 | 2024-11-01 | Amryt Endo Inc | Oral terlipressin compositions for use in treatment of ascites |
| CN112704727B (zh) * | 2021-01-12 | 2023-05-16 | 重庆医科大学附属第二医院 | 特利加压素在制备动力性肠梗阻药物中的应用 |
| CN113077888A (zh) * | 2021-03-30 | 2021-07-06 | 福州宜星大数据产业投资有限公司 | 自动化meld评分方法、终端及存储介质 |
| EP4472653A4 (en) * | 2022-02-03 | 2025-11-26 | Biovie Inc | METHODS OF TREATING A DISEASE WITH TERLIPRESSIN |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1188443A1 (en) * | 2000-09-15 | 2002-03-20 | Ferring BV | Improved protocol for paracentesis |
| EP1984012B1 (en) * | 2006-02-13 | 2015-12-30 | Ferring B.V. | Use of peptidic vasopressin receptor agonists |
| WO2009037586A2 (en) * | 2007-08-14 | 2009-03-26 | Ferring B.V. | Use of peptidic vasopressin receptor agonists |
| US20100311642A1 (en) * | 2007-09-28 | 2010-12-09 | Ferring B.V. | Use of v2 receptor antagonists in combination with vaso pressinergic agnosts |
| BRPI0819434A2 (pt) * | 2007-11-08 | 2019-09-24 | Univ Utah Res Found | método de tratamento ou prevenção de doenças hepáticas e uso de antagonistas á angiogênese em condições de proliferação venosa anormal |
| US8815232B2 (en) * | 2008-08-26 | 2014-08-26 | Kyon Biotech Ag | Compositions and methods for treating cancer |
| CN105132395A (zh) * | 2009-03-09 | 2015-12-09 | 生物蛋白有限公司 | Mirac蛋白 |
| JP5749255B2 (ja) * | 2009-06-08 | 2015-07-15 | ユーシーエル ビジネス ピーエルシー | Ｌ−オルニチンフェニル酢酸塩を用いる門脈圧亢進の治療及び肝機能の修復 |
| BR112013000744A2 (pt) * | 2010-07-14 | 2020-07-14 | Cumberland Emerging Technologies, Inc | uso de um antagonista de receptor de tromboxana a2 para prevenção ou tratamento de síndrome hepatorrenal,encefalopatia hepática,e doenças associadas |
| WO2013106072A1 (en) | 2012-01-10 | 2013-07-18 | Sorbent Therapeutics, Inc. | Compositions comprising crosslinked cation-binding polymers and uses thereof |
| JO3109B1 (ar) | 2012-05-10 | 2017-09-20 | Ferring Bv | منبهات لمستقبلات v1a |
| CN102731625B (zh) * | 2012-06-27 | 2014-10-15 | 深圳翰宇药业股份有限公司 | 一种纯化特利加压素的方法 |
| JP6378194B2 (ja) * | 2012-11-12 | 2018-08-22 | ザ リージェンツ オブ ザ ユニヴァーシティ オブ コロラド，ア ボディ コーポレイト | 慢性肝疾患の評価のための疾患重症度指数および原発性硬化性胆管炎の３つの異なるサブタイプの診断方法 |
| JP6522584B2 (ja) * | 2013-04-26 | 2019-05-29 | ラ ホヤ ファーマシューティカル カンパニーＬａ Ｊｏｌｌａ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏｍｐａｎｙ | 腎不全を処置するための組成物及び方法 |
| CN104510840A (zh) | 2013-08-21 | 2015-04-15 | 乔治亚摄政研究学院有限公司 | 改性绿茶多酚和其用于治疗肝病的方法 |
| JP2017014206A (ja) * | 2015-06-30 | 2017-01-19 | ナノアンティバイオティクス，インコーポレイテッド | 腹水の治療 |
-
2016
- 2016-06-29 JP JP2016128584A patent/JP2017014206A/ja active Pending
- 2016-06-30 HK HK19100970.3A patent/HK1258611A1/zh unknown
- 2016-06-30 EP EP23212473.5A patent/EP4338795A3/en active Pending
- 2016-06-30 WO PCT/US2016/040284 patent/WO2017004317A1/en not_active Ceased
- 2016-06-30 ES ES16818751T patent/ES2971959T3/es active Active
- 2016-06-30 EP EP16818751.6A patent/EP3347032B1/en active Active
- 2016-06-30 US US15/198,050 patent/US9655945B2/en not_active Expired - Fee Related
- 2016-06-30 CN CN201680003239.1A patent/CN106999539A/zh active Pending
- 2016-06-30 CN CN202510468211.6A patent/CN120324576A/zh active Pending
-
2017
- 2017-04-19 US US15/491,613 patent/US20180000887A1/en not_active Abandoned
-
2018
- 2018-08-02 JP JP2018145654A patent/JP2018172440A/ja active Pending
-
2019
- 2019-04-09 US US16/379,446 patent/US11364277B2/en active Active
-
2020
- 2020-07-03 JP JP2020115254A patent/JP2020172520A/ja active Pending
-
2022
- 2022-06-03 US US17/831,556 patent/US20230146264A1/en not_active Abandoned
- 2022-07-01 JP JP2022107055A patent/JP2022136104A/ja active Pending
-
2023
- 2023-08-18 JP JP2023133333A patent/JP2023160839A/ja active Pending
-
2024
- 2024-01-23 US US18/420,332 patent/US20240165193A1/en not_active Abandoned
-
2025
- 2025-06-12 US US19/236,445 patent/US20250312410A1/en active Pending
- 2025-06-25 JP JP2025107051A patent/JP2025143324A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017014206A5 (enExample) | ||
| JP2018172440A5 (enExample) | ||
| JP2018193377A5 (enExample) | ||
| JP2015083580A5 (enExample) | ||
| JP2016034978A5 (enExample) | ||
| JP2013525444A5 (enExample) | ||
| JP2012193216A5 (enExample) | ||
| EA201401028A1 (ru) | Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения | |
| JP2012512907A5 (enExample) | ||
| IL292465B2 (en) | Neuroactive compounds and methods of use thereof | |
| CN111836807A (zh) | 氧杂螺环类化合物及其制备方法和用途 | |
| JP2020097577A5 (enExample) | ||
| JP2017500289A5 (enExample) | ||
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2013166781A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| JP2013541583A5 (enExample) | ||
| JP2019529541A5 (enExample) | ||
| JP2017508817A5 (enExample) | ||
| JP2018509419A5 (enExample) | ||
| JP2018503644A5 (enExample) | ||
| JP2015522603A5 (enExample) | ||
| JP2019518022A5 (enExample) | ||
| JP2015507020A5 (enExample) | ||
| JP2014148552A5 (enExample) |